OCIAD2 Antibody

Product Specifications

CAS Number

9007-83-4

Gene Name

OCIA domain containing 2

Gene Aliases

OCIA domain-containing protein 2; ovarian cancer immunoreactive antigen domain containing 2; ovarian carcinoma immunoreactive antigen-like protein.

Gene ID

132299

Accession Number

https://www.ncbi.nlm.nih.gov/protein/NP_001014446

Reactivity

Human|Mouse|Rat

Immunogen

OCIAD2 antibody was raised against a 17 amino acid synthetic peptide from near the amino terminus of human OCIAD2. The immunogen is located within the first 50 amino acids of OCIAD2.

Target

Ovarian cancer immuno-reactive antigen domain-containing protein 2

Clonality

Polyclonal

Conjugation

Unconjugated

Type

Polyclonal Antibody

Applications

Enzyme-linked immunosorbent assay|Immunofluorescence|Western blot

Purification

Affinity Purified

Assay Protocol

Reconstitution & Storage Instructions Western Blotting/Immunoblotting (WB/IB) Protocol Immunohistochemistry (IHC) Protocol Immunocytochemistry (ICC) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Blocking Peptide Competition Protocol (BPCP) Immunoprecipitation (IP) Protocol Antibody Array (AA) Protocol Reconstitution & Storage Instructions Reconstitution & Storage Instructions Western Blotting/Immunoblotting (WB/IB) Protocol Western Blotting/Immunoblotting (WB/IB) Protocol Immunohistochemistry (IHC) Protocol Immunohistochemistry (IHC) Protocol Immunocytochemistry (ICC) Protocol Immunocytochemistry (ICC) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Blocking Peptide Competition Protocol (BPCP) Blocking Peptide Competition Protocol (BPCP) Immunoprecipitation (IP) Protocol Immunoprecipitation (IP) Protocol Antibody Array (AA) Protocol Antibody Array (AA) Protocol

Concentration

1 mg/ml

Homology

Human; Mouse; Rat

Format

Liquid. OCIAD2 Antibody is supplied in PBS containing 0.02% sodium azide.

Reconstitution

OCIAD2 antibody can be stored at 4C, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.